Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain
Status:
Terminated
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that Botulinum toxin A (BOTOX®) treatment reduces pain
and disability in subjects suffering from sub-acute low back pain due to an identifiable
muscle strain or back trauma occurring 6 to 16 weeks prior to enrollment. The study will also
delineate the duration of medication effect and control for any placebo or mechanical
trigger-point injection effect by employing a prospective, double-blind, placebo-controlled
design.
Phase:
Phase 4
Details
Lead Sponsor:
United States Department of Defense
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA